跳至主要内容
临床试验/NCT00633425
NCT00633425已完成4 期

Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride

Sanofi1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2002年10月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Sanofi
入组人数
43
试验地点
1
主要终点
Change in interstitial glucose levels between the observation and maintenance phases.

研究概览

简要总结

Analyse the glucose profile, based on continuous glucose monitoring by CGMS, in type 2 diabetics inadequately controlled by metformin, before and after the addition of Glimepiride.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men or women aged 35 to 70 years
  • Having given their consent
  • Type 2 diabetics (HBA1c greater than 6.5%
  • Fasting glycaemia greater than 1.40 g/l) not controlled by Metformin for at least 6 weeks.

排除标准

  • 未提供

结局指标

主要结局

Change in interstitial glucose levels between the observation and maintenance phases.

时间窗: The mean of 24 variations in average hourly glucose readings recorded by CGMS.

次要结局

  • HbA1c and fasting blood glucose levels.(Measured in the observation and maintenance phases, and change between the two phases.)

研究者

发起方
Sanofi
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Continuous Glucose Monitoring System (CGMS) in Type... | 临床试验